$ATR

APTARGROUP, INC.

No enriched coverage for $ATR in the last 7 days.

$3.5M
Prieur Marc
0%
See all $ATR insider activity →
Low

Touya Gael sold $500K of ATR

Touya Gael (Segment Pres., CEO Designate) sold 3,740 shares of APTARGROUP, INC. (ATR) at an average of $133.76 ($133.69–$134.55, $0.50M total) across 2 trades on 2026-08-27.

Aircraft order backlog to persist until 2030

Forecast International data cited by fDi says global aircraft order backlog for Airbus, Boeing, Embraer and ATR was 16,832 at end-July 2026, up 4.7% from end-2025. Deliveries rose to 1,503 in 2025 and are on track for 1,425 in 2026. Iata expects no meaningful backlog improvement before 2030 due to supply-chain bottlenecks, engine constraints, tariffs and labour shortages.

Publication of a Circular

Schroder Asian Total Return Investment Company plc (ATR) said it has published a circular for shareholders on a proposed combination with Pacific Assets Trust plc (PAC). The plan would use a scheme of reconstruction and PAC’s members’ voluntary winding-up, transferring most PAC assets and issuing New ATR shares. A cash option is capped at 25% with a 2% discount; shareholder approval is required.

ATR sentiment & insider activity

Recent ATR coverage spans insider activity, sector analysis and earnings.

In the last 30 days, ATR insiders filed 6 SEC Form 4 transactions — no purchases and 6 sales ($3.5M). The most active reporter was Prieur Marc, Segment President, with 2 filings.

What's driving ATR

  • Insider sell may signal weak confidence, modest downward pressure.

    SEC EDGAR · Aug 28, 2026

  • Extended backlog duration may support production planning, but the article highlights systemic supply-chain and engine bottlenecks.

    fdiintelligence.com · Aug 12, 2026

  • The circular is a key step toward shareholder votes on a reconstruction and members’ voluntary winding-up of PAC, with New ATR shares issued to PAC shareholders.

    investegate.co.uk · Aug 11, 2026

  • Earnings call provides fresh quarterly results, margin drivers, and explicit Q3 EPS guidance, setting near-term expectations for ATR.

    fool.com · Aug 8, 2026

  • This is a routine insider open-market sale by a segment president, with no stated 10b5-1 plan, but it does not disclose new company fundamentals.

    SEC EDGAR · Aug 5, 2026

alphai scores every news story that mentions ATR with an AI model for sentiment and relevance, and aggregates insider trades from APTARGROUP, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ATR

Score

Aircraft order backlog to persist until 2030

Forecast International data cited by fDi says global aircraft order backlog for Airbus, Boeing, Embraer and ATR was 16,832 at end-July 2026, up 4.7% from end-2025. Deliveries rose to 1,503 in 2025 and are on track for 1,425 in 2026. Iata expects no meaningful backlog improvement before 2030 due to supply-chain bottlenecks, engine constraints, tariffs and labour shortages.

Publication of a Circular

Schroder Asian Total Return Investment Company plc (ATR) said it has published a circular for shareholders on a proposed combination with Pacific Assets Trust plc (PAC). The plan would use a scheme of reconstruction and PAC’s members’ voluntary winding-up, transferring most PAC assets and issuing New ATR shares. A cash option is capped at 25% with a 2% discount; shareholder approval is required.

$ATRMedAI 8/10

Aptar (ATR) Q2 2026 Earnings Call Transcript

AptarGroup (ATR) reported Q2 2026 total sales of $1.03B, up 6% reported, with adjusted EPS of $1.42 above guidance. Adjusted EBITDA was $213M, down 3%, and margins fell due to mix and operational issues in beauty. Pharma core sales grew 8% excluding emergency medicine destocking. Net debt was $1.2B, leverage 1.49x, and Q3 adjusted EPS guidance is $1.45 to $1.53.

$ATRMed

APTARGROUP, INC. (ATR): Results of Operations and Financial Condition

APTARGROUP, INC. (ATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Aptar Reports Second Quarter 2026 Results Crystal Lake, Illinois, July 30, 2026 -- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following second quarter results

Aptar Pharma Announces GMP Certification at Nanopharm, Strengthening Its Integrated Pharma Services Offering

Aptar Pharma said the UK MHRA issued a Certificate of Good Manufacturing Practice compliance after inspecting its Nanopharm facility in Wales. The inspection found no critical observations and confirmed GMP compliance for Nanopharm’s cGMP analytical testing for orally inhaled and nasal drug products. Aptar said this expands regulated analytical services for customers across the product lifecycle.

Related tickers